高级搜索

肺癌患者组织和痰液中p53基因、K-ras基因突变

The Changes of p53、K-ras Gene in the Lung Cancer Tissues and Their Relevant Sputum

  • 摘要: 目的 探讨p53、K-ras基因在肺癌患者癌组织及相应痰液中改变情况及其联合检测在肺癌早期诊断中的价值。方法 对59例肺癌组织和14例肺部良性组织及相应痰液,应用PCR-SSCP-银染法检测了p53基因第5~8外显子突变情况;应用PCR-RFLP法对K-ras基因突变进行了检测。结果 p53基因在肺癌组织中突变率为37.3%,K-ras基因在肺腺癌突变率为48.0%,其它类型肺癌突变率仅为8.8%。相应痰液中两基因突变率分别为33.8%和44.0%,与组织中的突变率无明显差异,P<0.01。良性组织及相应痰液中两基因均无突变。吸烟患者的突变率(48.7%,68.5%)明显高于非吸烟患者的突变率(15.0%,11.1%),P<0.01;两基因的联合检测在肺癌的早期诊断中的价值(54.2%)明显优于单基因的检测,P<0.05。结论 痰液和组织中的基因突变率基本相似,即痰液中脱落细胞的分子遗传学改变能反映肺组织情况。因此以痰液为目标多基因的联合检测可能有助于肺癌的诊断。

     

    Abstract: Objective To assess the value of changes of p53 gene、K-ras gene in the lung cancer and two genes combined together for the detection of lung cancer. Methods In 59 case lung cancer cancer cases and 14 cases with benign respiratory diseases.PCR-SSCR-AgNO3 staining method was applied to detect the mutations of 5~8 exon of p53 gene;The mutations of first exon of K-ras gene were also detected by PCR-RFLP technique.Their relevant sputum were also studied. Results The frequency of p53、alteration was 37.3% while the frequency of K-ras alteration in adenocarcinema was 48.0%.These frequency of alteration in the sputum were 33.8% and 44.0%.No p53 and K-ras gene mutations was detected in the specimens of benign respiratory diseases.The changes of p53、K-ras gene showed no difference in the biopsy specimens and relevant sputum.The mutation rate of p53 and K-ras in smokers were 48.7% and 68.5%,while in non-smokers were 15.0% and 11.1%,P<0.01.The value of these two markers using together for detection of lung cancer was also assessed.The result showed that the sensitivity of two markers combined(54.2%) was obviously higher than that of single gene detection. Conclusion The changes of p53,K-ras are common in lung cancer.The genetic changes of sputum can reflect that of lung biopsy.The detection of several kinds of molecular genetic markers together in sputum may help the diagnosis of lung cancer.

     

/

返回文章
返回